Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05626296

Molecular Network Characteristics of Phlegm-heat Syndrome in Ischemic Stroke Based on Multi-omics Integrated Analysis

Status
Recruiting
Phase
Study type
Observational
Enrollment
24 (estimated)
Sponsor
Dongzhimen Hospital, Beijing · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

The molecular characteristics of ischemic stroke with phlegm-heat syndrome and candidate biomarkers were identified based on multi-omics data. The main purpose of this study is to validate the molecular characteristics and biomarkers of phlegm-heat syndrome in ischemic stroke, and to demonstrate the association of biomarkers with clinical outcomes.

Detailed description

This is a cohort study in patients with ischemic stroke. The demographic characteristics, TCM syndromes, and other baseline information will be recorded. At the same time, baseline peripheral blood will be collected. These participants will be followed up to 90 days of onset, and 90-day modified Rankin scale (mRS) scores will be assessed. The collected blood samples will be tested by multi-factor detection technology for candidate biomarkers.

Conditions

Timeline

Start date
2022-11-14
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2022-11-23
Last updated
2024-06-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05626296. Inclusion in this directory is not an endorsement.

Molecular Network Characteristics of Phlegm-heat Syndrome in Ischemic Stroke Based on Multi-omics Integrated Analysis (NCT05626296) · Clinical Trials Directory